Please see below all current skin cancer clinical trials of the Central Coast Cancer Centre.
A randomized, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous squamous cell carcinoma.
Principal Investigator: Dr Craig Kukard
Study Coordinator: Cassandra Rubio
Condition: Skin Cancer
More information about c-POST
For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see: